Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection

The present study aimed to demonstrate the potential advantage of oral uracil-tegafur (UFUR)/leucovorin (LV) as the subsequent therapy in patients with stage III colon cancer following adjuvant LV, 5-fluorouracil and oxaliplatin (FOLFOX4) chemotherapy. Of a total 143 patients, 62 patients received o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Autores principales: Huang, Ming-Yii, Huang, Chun-Ming, Tsai, Hsiang-Lin, Huang, Ching-Wen, Hsieh, Hui-Min, Yeh, Yung-Sung, Wu, Jeng-Yih, Wang, Wen-Ming, Wang, Jaw-Yuan
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686528/
https://ncbi.nlm.nih.gov/pubmed/29163699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7073
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares